Skip to content

Shire U.S., Inc. v. Blackburn

Petition for certiorari denied on October 2, 2023

Docket No. Op. Below Argument Opinion Vote Author Term
22-1180 11th Cir. N/A N/A N/A N/A OT 2023

Issue: Whether a state-law claim is preempted if it places a duty on a drug manufacturer to unilaterally change language approved by the Food and Drug Administration that appears in the highlights section of a drug label.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
03/21/2023Application (22A846) to extend the time to file a petition for a writ of certiorari from April 5, 2023 to May 5, 2023, submitted to Justice Thomas.
03/29/2023Application (22A846) granted by Justice Thomas extending the time to file until May 5, 2023.
04/18/2023Application (22A846) to extend further the time from May 5, 2023 to June 4, 2023, submitted to Justice Thomas.
04/25/2023Application (22A846) granted by Justice Thomas extending the time to file until June 4, 2023.
06/02/2023Petition for a writ of certiorari filed. (Response due July 7, 2023)
06/22/2023Motion to extend the time to file a response from July 7, 2023 to August 7, 2023, submitted to The Clerk.
06/23/2023Motion to extend the time to file a response is granted and the time is extended to and including August 7, 2023.
07/07/2023Amicus brief of Pharmaceutical Research Manufacturers of America not accepted for filing (duplicate electronic filing). (July 12, 2023)
07/07/2023Brief amicus curiae of Pharmaceutical Research Manufacturers of America filed.
07/12/2023Brief of respondent Mark Blackburn in opposition filed.
07/26/2023DISTRIBUTED for Conference of 9/26/2023.
07/26/2023Reply of petitioners Shire US Inc., et al. filed. (Distributed)
10/02/2023Petition DENIED.